We found FBXW11 to be significantly enriched in binding site mutations in colon adenocarcinoma (FDR < 0.1), and of borderline significance in glioblastoma multiforme (FDR = 0.104) ( Figure 4 ).
1
—
—
We found FBXW11 to be significantly enriched in binding site mutations in colon adenocarcinoma (FDR < 0.1), and of borderline significance in glioblastoma multiforme (FDR = 0.104) ( Figure 4 ).